ResearchMoz

Research on China's PVP (Polyvinyl Pyrrolidone) Industry, 2013-2017

Huidian Research
Published Date » 2012-12-14
No. Of Pages » 76
   
 There are more than a dozen PVP manufacturers in China, and the total production capacity is more than 20,000 tons; in 2012, the output was about 11,200 tons, increased by 180% compares with 2007, of which, more than 30% of the products are used to exports. It is can be seen from the statistics of production capacity and output that the actual PVP production capacity is already in the overcapacity state. At the same time, some China's products cannot reach the quality requirements of some industries, and nearly 20% of China's PVP consumption needs to be imported. 
   
 In 2012, China's PVP demand volume was nearly 10,082 tons and the demand mainly come from medicine, everyday chemicals and office supplies. Due to the development of downstream industries, the PVP consumption will...
Table of Content

1. PVP Industry
1.1 PVP
1.1.1 Properties
1.1.2 Application Areas
1.2 Production Technologies
1.2.1 PVP Monomer NVP Synthetic Technology
1.2.2 NVP Monomer Purification Technology
1.2.3 PVP Polymerization Technology and Complexation Technology
1.2.4 PVP Polymer Drying Technology
1.3 Upstream and Downstream of PVP Industry
1.3.1 Business Model and Industry Characteristics
1.3.2 Upstream and Downstream
1.3.3 Relationship of Upstream Industries
1.3.4 Relationship of Downstream Industries

2. Development Backgrounds of China's PVP Industry
2.1 Economic Development Environment
2.1.1 Economic Development Situation
2.1.2 GDP
2.1.3 Investment in the Fixed Assets
2.1.4 Total Export-Import Volume and the Growth Rate
2.1.5 Forecast of Macro-economy
2.2 DownstreamDaily Chemicals
2.2.1 Industrial Operation
2.2.2 Industrial Policy

3. Global PVP Market
3.1 Production Situation
3.1.1 Status Quo
3.1.2 Competitive Landscape
3.2 Key Enterprises
3.2.1 BASF (Germany)
3.2.2 ISP (the United States)
3.2.3 Nippon Shokubai Co., Ltd.
3.3 Application and Consumption of Global PVP Industry
3.3.1 Consumption
3.3.2 Application Areas
3.4 Downstream Industries
3.4.1 Global Daily Chemical Industry
3.4.2 Global Pharmaceuticals Industry

4. China's PVP Market
4.1 Industry Management System and Policies
4.1.1 Authorities and Supervision System
4.1.2 Market Access, Laws and Regulations
4.1.3 Industry Policies
4.2 Production Capacity and Output of China's PVP Industry
4.2.1 Industry Development
4.2.2 Production Capacity and Output from 2007 to 2012
4.2.3 Output Forecast from 2013 to 2017
4.3 China's PVP Application and Consumption
4.3.1 Consumption Scale
4.3.2 Consumption Areas
4.3.3 New Consumption Areas in the Future
4.4 Competitive Landscape
4.4.1 Competitive Landscape
4.4.2 Entry Barriers

5. Competitiveness of China's PVP Enterprises
5.1 Boai NKY Pharmaceuticals Ltd.
5.1.1 Company Profile
5.1.2 Products
5.1.3 Industry Position
5.1.4 Production Capacity
5.1.5 Operation from 2011 to 2012
5.1.6 Competitive Advantages
5.2 Hangzhou Nanhang Industrial Co., Ltd.
5.2.1 Company Profile
5.2.2 Operation
5.3 Shenhua Scientific & Technical Development Co., Ltd.
5.3.1 Company Profile
5.3.2 Operation
5.4 Anhui Haifeng Fine Chemical Co., Ltd.
5.4.1 Company Profile
5.4.2 Operation
5.5 Jiaozuo Yuanhai Fine Chemical Co., Ltd.
5.5.1 Company Profile
5.5.2 Operation
5.6 Jiaozuo Meida Fine Chemical Co., Ltd.
5.6.1 Company Profile
5.6.2 Operation

6. Prospect and Development Forecast of PVP Industry from 2011 to 2012
6.1 Development Prospect
6.1.1 Positive Factors
6.1.2 Negative Factors
6.2 Investment Risk
6.2.1 Environmental Protection Policy Risk
6.2.2 Influence of Foreign Quality Standards and Safety Certificates
6.2.3 Franchising License Renewal Risk
6.2.4 Risk of Serious Accidents Due to Poor Quality
6.2.5 Risk of Serious Safety Accidents
6.3 Development Trend
6.3.1 The Development of Global Pharmaceuticals Industry Will Drive the Consumption Increase of PVP
6.3.2 The Development of Global Everyday Chemical Industry Will Drive the Consumption Increase of PVP
6.3.3 New Application Areas Will Increase Continuously

List of Tables

NA

List of Figures

NA

Upcoming Reports:

Greece: market of aluminum alloy plates, sheets and strips
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the aluminum alloy plates, sheets and strips market in Greece and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the aluminum alloy plates, sheets and strips market in Greece, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the...
Stethoscopes Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts 2012-2018
By - Transparency Market Research
Development of electronic stethoscope is gaining an edge over traditional stethoscopes mainly due to enhanced digital sound transmission capabilities of digital stethoscopes and their increasing use in telemedicine. Despite of invention of advanced technologies like handheld ultrasound systems, stethoscopes are mostly preferred by healthcare professionals for physical examination. Global stethoscope market is estimated to grow and reach $342 million over the year 2017 as a result of increasing demand for electronic stethoscope and fetal heart rate detectors. This market is also...
Greece: market of bran, sharps and other residues
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the bran, sharps and other residues market in Greece and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the bran, sharps and other residues market in Greece, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Order cancellations not a sign of market slump: Airbus
Jul 31, 2014  
Leading aircraft manufacturer Airbus on Wednesday said that the recent wave of order cancellations for its commercial jetliners do not mean that the market has declined. The market is still strong and single-aisle jets deals are likely to return later. A total of 225 Airbus cancellations were reported since the beginning of this year. Of these, Dubai’s Emirates Airlines alone...
Leading Australian Universities Want to Hike Fees, Enroll Fewer Students
Jul 31, 2014  
Australia’s prestigious group of top eight universities, also known as the Group of Eight (Go8), has indicated plans of increasing tuition fees while reducing the number of students they enroll, a reform-backer has predicted. These decisions could be made if the universities are deregulated .  Arguing for this decision, the chairman of Go8, and vice chancellor of the ANU, Ian...
Bristol-Myers Squibb Posts USD 3.9 billion Revenues in 2014 Second Quarter
Jul 30, 2014  
Leading bio-pharmaceutical company Bristol-Myers Squibb has registered revenues of USD 3.9 billion in the 2014 second quarter. This marks a 4% decrease from the same period in 2013. The global revenues of the company (excluding the divested Diabetes Alliance), saw a 7% increase. In this quarter, the company’s results were underlined by steady global sales of nearly each of its...
Novartiss Simbrinza gets approval from the EU
Jul 30, 2014  
Glaucoma patients in Europe can easily obtain Novartis’ Simbrinza eye drops which are a combination of brimonidine tartrate and brinzolamide and it is without a beta-blocker. This eye drop has got the approval of the European Commission. Unlike the inefficient treatment provided by monotherapy, this eye drop aims at treating intraocular pressure or IOP in adults with ocular hypertension...
Second Treaty Between Zealand And Boehringer Ingelheim
Jul 30, 2014  
Denmark based Pharma group Zealand Pharma and Germany’s Boehringer Ingelheim have signed an accord to formulate new medicines for advanced and effective treatment of cardio-metabolic maladies. The collaboration between these two Pharma groups involves a new therapeutic peptide project from the list of preclinical programs of Zealand Pharma.  Both these companies are aiming...